Skip to main content

Becker Muscular Dystrophy clinical trials at UC Health
2 in progress, 1 open to new patients

  • Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)

    open to eligible males ages 18-60

    (-)-Epicatechin will be evaluated for the treatment of progressive muscle loss and impaired skeletal muscle function in Becker Muscular Dystrophy (BMD) patients.

    at UC Davis

  • Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping

    Sorry, in progress, not accepting new patients

    This is a multi-center natural history study that will be conducted at participating centers in the Cooperative International Neuromuscular Research Group (CINRG). Following a baseline evaluation, participants will have three follow-up visits over a three-year period. The investigators will characterize the Becker muscular dystrophy phenotype, and correlate specific abnormal dystrophin proteins with the range of clinical outcomes.

    at UC Davis

Last updated: